Evoke has raised £153,907 ($202,000) for the Motor Neurone Disease (MND) Association at its second annual Charity Gala, held on 13 November at the Royal Armouries Museum in Leeds.
The total surpasses last year's fundraising figure and reinforces the company's position as the MND Association's highest-ever corporate contributor.
More than 500 guests attended the event, including employees from Evoke's global offices, partners and several celebrity ambassadors affiliated with the group's brands. The evening featured entertainment, dinner and a variety of fundraising activities.
The milestone follows a year of joint initiatives, including a Charity Race Day at Ripon Racecourse.
During the gala, Evoke confirmed a two-year extension of its partnership with the MND Association and set a new collective fundraising target exceeding £1m.
Funds raised will support the charity's work to improve access to care, finance research and advocate for people living with MND.
The partnership, first established in 2024, was informed by a colleague-led review and reflects a personal connection within the business: the niece of an Evoke regional operations manager was diagnosed with MND at the age of 26.
MND continues to affect thousands of people across the UK, including in Leeds, where the death of former Leeds Rhinos player Rob Burrow brought renewed national attention to the condition. Around 5,000 people are diagnosed with the disease each year.
The announcement comes shortly after board changes at Evoke. In October, the company confirmed that Lord Jon Mendelsohn had stepped down as Chair, with Mark Summerfield appointed as his successor and Anne de Kerckhove named Deputy Chair.
Evoke's partnership with the MND Association began in 2024 after employees voted on the company's first long-term charity partner
